O. C. Burghuber (Vienna, Austria), A. Agusti (Palma De Mallorca, Spain)
Exacerbation frequency and increased risk of myocardial infarction in COPD
J. R. Hurst, G. C. Donaldson, C. J. Smith, R. B. Hubbard, J. A. Wedzicha (London, Nottingham, United Kingdom)
|  |
Fractal behaviour of heart rate variability reflects severity of COPD
G. D‘Addio, C. Graziamaria, A. Agostino, R. Franco, C. Andrea, A. I. Raffaele (Telese Terme, Campobasso, Trieste, Naples, Cosenza, Rome, Italy)
|  |
Neglected COPD and chronic comorbidities in elderly patients with chronic heart failure
P. Boschetto, D. Beltrame, A. Potena, L. Ballerin, N. Lo Cascio, L. M. Fabbri, C. E. Mapp, E. De Rosa, A. Fucili, C. Ceconi, R. Ferrari (Ferrara, Modena, Italy)
| |
Echocardiographic evaluation of COPD patients in different stages of the disease
K. Dela Coleta, D. Fernandes Lima, B. Bojikian Matsubara, I. Godoy, K. Okoshi (Botucatu/SP, Brazil)
|  |
Osteoporosis, vertebral fracture and bone metabolism in COPD patients
B. Kennedy, M. Healy, J. Keane, F. O‘Connell, J. B. Walsh, M. Casey (Dublin, Ireland)
| |
COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control
T. Cappelletti, E. Orsi, V. Valenti, E. Lunati, P. Beck Peccoz, F. Blasi, L. Allegra (Milan, San Donato Milanese, Italy)
| |
Body mass index (BMI) is an independent risk factor for exacerbation in patients with COPD
Y. Nasuhara, H. Makita, M. Hasegawa, K. Nagai, T. Betsuyaku, M. Nishimura (Sapporo, Japan)
| |
Co-morbidities are not associated with severity of airflow obstruction as measured by ATS/ERS/GOLD in patients with COPD
C. Cote, B. Celli (Bay Pines, FL, Boston, MA, United States Of America)
| |